TCR V delta 2 Antibody (B6) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-11706F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # B6
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant TCR Vdelta2
Specificity
The mouse monoclonal antibody B6 recognizes an extracellular epitope of human TCR V delta 2, which is expressed on the majority of gamma/delta T cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Scientific Data Images for TCR V delta 2 Antibody (B6) [FITC]
TCR V delta 2 Antibody (B6) [FITC] [NBP3-11706F] -
TCR V delta 2 Antibody (B6) [FITC] [NBP3-11706F] - Vial of FITC conjugated antibody. FITC is optimally excited at 498 nm by the Blue laser (488 nm) and has an emission maximum of 519 nm.Applications for TCR V delta 2 Antibody (B6) [FITC]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TCR V delta 2
Alternate Names
hDV102S1
Gene Symbol
TRDV2
Additional TCR V delta 2 Products
Product Documents for TCR V delta 2 Antibody (B6) [FITC]
Product Specific Notices for TCR V delta 2 Antibody (B6) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...